Clinical Trial Update: Phase I Study of GW856553 (Losmapimod) [Phase 1]

View source ↗

Summary

Phase 1 study of Losmapimod (GW856553) in Acute Coronary Syndrome has completed, evaluating safety and pharmacokinetics. The trial was sponsored by GlaxoSmithKl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome

Drugs mentioned

• Losmapimod (losmapimod)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Acute Coronary Syndrome | Phase 1 | Status: COMPLETED